Squarepoint’s Mesa Laboratories MLAB Stock Holding History

Squarepoint’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,187	Closed	-$282K	–	4755
2026 Q1	$282K	Buy	3,187 +440	+16%	+$37.9K	﹤0.01%	3757
2025 Q4	$216K	Buy	+2,747	New	+$209K	﹤0.01%	3817
2025 Q1	–	Sell	-2,225	Closed	-$293K	–	5103
2024 Q4	$293K	Buy	+2,225	New	+$273K	﹤0.01%	4159
2024 Q1	–	Sell	-3,608	Closed	-$378K	–	4368
2023 Q4	$378K	Buy	+3,608	New	+$352K	﹤0.01%	3207
2023 Q3	–	Sell	-1,959	Closed	-$252K	–	4068
2023 Q2	$252K	Buy	+1,959	New	+$299K	﹤0.01%	3074
2023 Q1	–	Sell	-1,268	Closed	-$211K	–	3563
2022 Q4	$211K	Buy	+1,268	New	+$199K	﹤0.01%	2752
2021 Q2	–	Sell	-882	Closed	-$215K	–	3518
2021 Q1	$215K	Buy	+882	New	+$243K	﹤0.01%	2662
2020 Q3	–	Sell	-3,129	Closed	-$678K	–	2704
2020 Q2	$678K	Buy	+3,129	New	+$721K	0.01%	1140
2019 Q2	–	Sell	-1,252	Closed	-$289K	–	2561
2019 Q1	$289K	Buy	+1,252	New	+$283K	﹤0.01%	1788
2018 Q4	–	Sell	-1,216	Closed	-$226K	–	2128
2018 Q3	$226K	Buy	+1,216	New	+$245K	﹤0.01%	1700

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Squarepoint's MLAB Position: Q2 2026 in Review

Squarepoint sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 3,187 shares — an estimated $282K sold.

Squarepoint first reported a position in MLAB in Q3 2018 and held it in 10 quarters. The position peaked at $678K in Q2 2020. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Squarepoint reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 3,187 Mesa Laboratories shares in Q2 2026, an estimated $282K.
Squarepoint first reported a position in Mesa Laboratories in Q3 2018 and held it in 10 quarters.
Squarepoint's Mesa Laboratories position peaked at $678K in Q2 2020.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.